The Lavender strain meshes together a diverse sampling of cannabis strains from exotic locations including Afghanistan, Europe, Korea, Hawaii and other U.S. states. It ends up as a 3-way cross between Big Skunk Korean, Afghani Hawaiian and Super Skunk that has a couch lock effect, making it great for getting a good nights sleep.
Mexico Legalizes Medical Marijuana
Blueberry Kush (Indica)
Blueberry is a mostly indica hybrid that provides a pleasant and long-lasting high when smoked. This marijuana has a sweet fruity smell and tastes like blueberries. Dutch Passion's version of Blueberry, which was derived from the original Delta 9 Collection, won first place in the 2000 High Times Cannabis Cup in the mostly indica category.
After State Legalizes Recreational Pot, Governor Wants to End Medical Marijuana
Governor Paul LePage failed to convince Maine voters that legalizing recreational marijuana would be a “deadly” disaster for the state. So now, the avowed Donald Trump supporter is trying to do away with medical marijuana.
Maine voters on Election Day appeared to narrowly approve Question 1, which legalizes two and a half ounces of cannabis and six mature plants for adults 21 and over. But with the margin of victory less than one percent of the vote, legalization opponents called for a recount.
Results from the recount, already delayed thanks to a lack of volunteers from the opposing side to help count, will now have to wait until 2017, as state election officials paused the process Friday for a two-week winter holiday break.
What strain are you smoking on today?
Company Behind CBD-Based Drug Leads Way Despite Trump, Economic Fears
Having expressed understandable apprehension due to recent political events in the U.S. and Britain (i.e. Trump’s election and Brexit), London-based GW Pharmaceuticals announced on Monday that they suffered a 62 percent revenue drop for 2016.
However, things turned around quickly.
GW’s stock jumped 5.5 percent on the first day of the new trading week, right after the company announced positive results for one of its flagship therapies, Epidiolex. This cannabidiol-based drug treats two of the most difficult-to-treat forms of epilepsy, especially in children: Dravet Syndrome and Lennox-Gastaut Syndrome.
“We are making very good progress toward a NDA [UK’s equivalent of the FDA] submission to the FDA, as well as preparations for commercial launch and look forward to the opportunity to make this important new medicine available to patients as quickly as possible,” said Justin Glover, GW’s Chief Executive Officer, on the company’s website.
- 192,622 Views Category: Odd
- 151,682 Views Category: Fun
- 141,212 Views Category: Culture
- 103,165 Views Category: Culture
- 101,716 Views Category: Culture
- 100,846 Views Category: Fun
- 81,424 Views Category: Culture
- 79,579 Views Category: Odd
- 71,521 Views Category: Fun
- 64,918 Views Category: Fun